Slow hemodialysis (HD) was performed for 10 h during the day in 11 critically ill patients with renal failure. The dialysis method was a modification of the pump-driven continuous venovenous HD. A nonsterile bicarbonate-containing hemodialysate was passed into the EVAL membrane dialyzer at a flow rate of 30 ml/min. No patient developed further hemodynamic instability during the treatment. The serum urea level was maintained below 20 mmol/l within 4 days of initiating the treatment. It allowed the patients to rest without interruption at night. This method was safely conducted by general nursing staff under the supervision of nephrologists on duty during the day. This schedule offers an approach to renal replacement therapy for hemodynamically unstable patients without any potential problem in the extracorporeal circulation at night.

Download full-text PDF

Source
http://dx.doi.org/10.1159/000187885DOI Listing

Publication Analysis

Top Keywords

slow hemodialysis
8
hemodialysis performed
8
performed day
8
renal failure
8
critically ill
8
ill patients
8
day managing
4
managing renal
4
failure critically
4
patients
4

Similar Publications

This article provides an overview of treatment approaches for chronic kidney disease (CKD) in patients with IgA nephropathy (IgAN). IgAN is the most common primary glomerulonephritis and results from an autoimmune reaction to aberrantly glycosylated immunoglobulin A (IgA) antibodies. Although historically considered largely benign, it is now recognized that a significant percentage of patients develop dialysis-dependent kidney disease over the years.

View Article and Find Full Text PDF

Background: The serum calcification propensity test (or T50 test) might become a standard tool for the assessment of vascular calcification risk and T50 might be a valuable biomarker in clinical trials of treatments intended to slow the progression of vascular calcification. Literature data suggest that non-calcium-containing phosphate binders can influence T50 in chronic dialysed patients. However, it is not clear whether similar interventions are effective in patients at earlier stages of chronic kidney disease (CKD).

View Article and Find Full Text PDF

Traditional, alternative, and emerging therapeutics for focal segmental glomerulosclerosis.

Expert Opin Pharmacother

January 2025

Unit of Nephrology and Dialysis, Department of Clinical and Experimental Medicine, A.O.U. "G.Martino", University of Messina, Messina, Italy.

Introduction: Segmental focal glomerulosclerosis is a histological lesion characterized by podocyte damage. It may be a primary disease linked to an unknown circulating factor, secondary to viral infections, drug toxicity, or a disadaptive response to the loss of nephrons, or it may depend on gene mutations or have an indeterminate cause. The treatment of the primary form involves immunosuppressors.

View Article and Find Full Text PDF
Article Synopsis
  • Atherosclerotic cardiovascular disease is a major health concern for individuals with type 2 diabetes (T2D) and chronic kidney disease (CKD), but GLP-1 receptor agonists (GLP-1RAs) can help reduce cardiovascular risks, improve blood sugar levels, and promote weight loss despite low usage rates due to safety concerns.
  • In a retrospective study involving 236 patients, those taking GLP-1RAs showed a significantly greater average weight loss (-9.6%) and better reduction in HbA1c levels (-1.0%) after 36 months compared to those on dipeptidyl-peptidase 4 inhibitors (DPP-4is), who lost only -2.4
View Article and Find Full Text PDF

Sulforaphane alleviates renal fibrosis through dual regulation on mTOR-mediated autophagy pathway.

Int Urol Nephrol

November 2024

Department of Nephrology, Zhongshan Hospital, Fudan University, No. 180 Fenglin Road, Shanghai, 200032, China.

Renal fibrosis is a common pathological process of progressive chronic kidney disease (CKD). However, effective therapy is constrained currently. Autophagy is an important mechanism in kidney injury and repairment but its exact role in renal fibrosis was discrepant according to previous studies.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!